![Joseph Wagner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Joseph P.
Wagner served as Chief Executive Officer at Insight Molecular Diagnostics, Inc. Served as President, Chief Executive Officer & Director at BriaCell Therapeutics Corp.
from 2015 to 2016.
Served as Executive Director at University of California Drug Discovery Consortium.
Served as Vice President-Cellular Therapy at Neuronyx, Inc. Served as President at Cell Targeting, Inc. Served as Chief Scientific Officer at Notable Labs Ltd. from 2020 to 2024.
Education includes undergraduate studies at Rochester Christian University and a doctorate from Duke University School of Medicine.
Anciens postes connus de Joseph Wagner
| Sociétés | Poste | Fin |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Directeur Général | 24/03/2016 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Corporate Officer/Principal | 13/10/2009 |
University of California Drug Discovery Consortium | Directeur/Membre du Conseil | - |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions | President | - |
Formation de Joseph Wagner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BriaCell Therapeutics Corp.
 BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
University of California Drug Discovery Consortium |
